wr 151327 has been researched along with amifostine anhydrous in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connor, AM; Grdina, DJ; Hanson, WR; Sigdestad, CP | 1 |
| Giambarresi, LI; Jackson, WE; Jacobs, AJ; Steel, LK | 1 |
| Kalebic, T; Schein, PS | 1 |
| Bensely, D; Green, D; Schein, P | 1 |
| Garnes, BA; Grdina, DJ; Nagy, B | 1 |
| Grdina, DJ; Kataoka, Y; Murley, J; Paunesku, D; Paunesku, T; Wahl, A; Woloschak, GE | 1 |
6 other study(ies) available for wr 151327 and amifostine anhydrous
| Article | Year |
|---|---|
A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327.
Topics: Amifostine; Animals; Cell Survival; Cobalt Radioisotopes; Digestive System; Energy Transfer; Gamma Rays; Lethal Dose 50; Mice; Mice, Inbred Strains; Neutrons; Organothiophosphorus Compounds; Radiation-Protective Agents; Stem Cells | 1986 |
Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
Topics: Amifostine; Animals; Female; Male; Mice; Neutrons; Organothiophosphorus Compounds; Radiation Dosage; Radiation-Protective Agents; Sex Factors; Time Factors; Whole-Body Irradiation | 1987 |
Organic thiophosphate WR-151327 suppresses expression of HIV in chronically infected cells.
Topics: Amifostine; Cell Line; Cytokines; HIV Infections; HIV Reverse Transcriptase; HIV-1; Organothiophosphorus Compounds; RNA-Directed DNA Polymerase; Sulfhydryl Compounds | 1994 |
Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Topics: Administration, Oral; Amifostine; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Hematopoietic Stem Cells; Injections, Intraperitoneal; Leukemia P388; Leukocytes; Leukopenia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; Organothiophosphorus Compounds; Radiation-Protective Agents | 1994 |
Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons.
Topics: Amifostine; Animals; Female; Gamma Rays; Male; Mice; Mice, Inbred Strains; Mutagenesis; Neoplasms, Radiation-Induced; Neutrons; Organothiophosphorus Compounds; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Sex Factors; Survival Rate; Time Factors | 1992 |
Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine.
Topics: Amifostine; Animals; Female; Gamma Rays; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neutrons; Organothiophosphorus Compounds; Radiation-Protective Agents; Whole-Body Irradiation | 2008 |